81 FR 35372 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 106 (June 2, 2016)

Page Range		35372-35372
FR Document		2016-12898

Federal Register, Volume 81 Issue 106 (Thursday, June 2, 2016)

[Federal Register Volume 81, Number 106 (Thursday, June 2, 2016)]
[Notices]
[Page 35372]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12898]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c) (6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR13-280: Program Project: Mechanisms of Membrane Fusion.
    Date: June 14, 2016.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: David R Jollie, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4150, MSC 7806, Bethesda, MD 
20892, (301)-435-1722, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Clinical Neuroplasticity and 
Neurotransmitters Study Section.
    Date: June 16-17, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue NW., 
Washington, DC 20036.
    Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group; Myocardial Ischemia and Metabolism Study 
Section.
    Date: June 23-24, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814
    Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301-435-
5575, [email protected].

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Developmental Brain Disorders Study 
Section.
    Date: June 23-24, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Avenue NW., Washington, 
DC 20037.
    Contact Person: Pat Manos, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-408-
9866, [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Chemo/Dietary Prevention Study Section.
    Date: June 23-24, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Warwick Seattle Hotel, 401 Lenora Street, Seattle, WA 
98121.
    Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-
594-7945, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Drug Discovery and Mechanisms of Antimicrobial Resistance.
    Date: June 23, 2016.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: American Inn of Bethesda, 8130 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: John C Pugh, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


    Dated: May 26, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-12898 Filed 6-1-16; 8:45 am]
BILLING CODE 4140-01-P

35372 Federal Register / Vol. 81, No. 106 / Thursday, June 2, 2016 / Notices

Dated: May 27, 2016. This notice is being published less than 15 Dated: May 26, 2016.
Natasha M. Copeland, days prior to the meeting due to the timing David Clary,
limitations imposed by the review and
Program Analyst, Office of Federal Advisory Program Analyst, Office of Federal Advisory
funding cycle.
Committee Policy. Committee Policy.
Name of Committee: Cardiovascular and
[FR Doc. 2016–12998 Filed 6–1–16; 8:45 am] [FR Doc. 2016–12898 Filed 6–1–16; 8:45 am]
Respiratory Sciences Integrated Review
BILLING CODE 4140–01–P Group; Myocardial Ischemia and Metabolism BILLING CODE 4140–01–P
Study Section.
Date: June 23–24, 2016.
DEPARTMENT OF HEALTH AND Time: 8:00 a.m. to 5:00 p.m. DEPARTMENT OF HEALTH AND
HUMAN SERVICES Agenda: To review and evaluate grant HUMAN SERVICES
applications.
National Institutes of Health Place: Hyatt Regency Bethesda, One National Institutes of Health
Bethesda Metro Center, 7400 Wisconsin
Center for Scientific Review; Notice of Avenue, Bethesda, MD 20814 Government-Owned Inventions;
Closed Meetings Contact Person: Kimm Hamann, Ph.D., Availability for Licensing
Scientific Review Officer, Center for
Pursuant to section 10(d) of the Scientific Review, National Institutes of AGENCY: National Institutes of Health.
Federal Advisory Committee Act, as Health, 6701 Rockledge Drive, Room 4118A, ACTION: Notice.
amended (5 U.S.C. App.), notice is MSC 7814, Bethesda, MD 20892, 301–435–
hereby given of the following meetings. 5575, hamannkj@csr.nih.gov. SUMMARY: The inventions listed below
The meetings will be closed to the Name of Committee: Brain Disorders and are owned by an agency of the U.S.
public in accordance with the Clinical Neuroscience Integrated Review Government and are available for
Group; Developmental Brain Disorders Study licensing in the U.S. in accordance with
provisions set forth in sections
Section. 35 U.S.C. 209 and 37 CFR part 404 to
552b(c)(4) and 552b(c) (6), Title 5 Date: June 23–24, 2016.
U.S.C., as amended. The grant Time: 8:00 a.m. to 5:00 p.m. achieve expeditious commercialization
applications and the discussions could Agenda: To review and evaluate grant of results of federally-funded research
disclose confidential trade secrets or applications. and development.
commercial property such as patentable Place: Melrose Hotel, 2430 Pennsylvania FOR FURTHER INFORMATION CONTACT:
material, and personal information Avenue NW., Washington, DC 20037. Licensing information may be obtained
concerning individuals associated with Contact Person: Pat Manos, Ph.D., by emailing the indicated licensing
Scientific Review Officer, Center for
the grant applications, the disclosure of contact at the National Heart, Lung, and
Scientific Review, National Institutes of
which would constitute a clearly Health, 6701 Rockledge Drive, Room 5200, Blood, Office of Technology Transfer
unwarranted invasion of personal MSC 7846, Bethesda, MD 20892, 301–408– and Development Office of Technology
privacy. 9866, manospa@csr.nih.gov. Transfer, 31 Center Drive Room 4A29,
Name of Committee: Center for Scientific Name of Committee: Oncology 2— MSC2479, Bethesda, MD 20892–2479;
Review Special Emphasis Panel; PAR13–280: Translational Clinical Integrated Review telephone: 301–402–5579. A signed
Program Project: Mechanisms of Membrane Group; Chemo/Dietary Prevention Study Confidential Disclosure Agreement may
Fusion. Section. be required to receive any unpublished
Date: June 14, 2016. Date: June 23–24, 2016. information.
Time: 12:00 p.m. to 4:00 p.m. Time: 8:00 a.m. to 5:00 p.m. SUPPLEMENTARY INFORMATION:
Agenda: To review and evaluate grant Agenda: To review and evaluate grant
applications. applications.
Technology description follows.
Place: National Institutes of Health, 6701 Place: Warwick Seattle Hotel, 401 Lenora Albumin Binding Immunomodulatory
Rockledge Drive, Bethesda, MD 20892, Street, Seattle, WA 98121. Compositions
(Virtual Meeting). Contact Person: Svetlana Kotliarova, Ph.D.,
Contact Person: David R Jollie, Ph.D., Scientific Review Officer, Center for The invention relates to molecules
Scientific Review Officer, Center for Scientific Review, National Institutes of wherein Evan’s Blue dye is chemically
Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, conjugated to CpG Oligonucleotides that
Health, 6701 Rockledge Drive, Room 4150, Bethesda, MD 20892, 301–594–7945, elicit anti-tumoral or infection fighting
MSC 7806, Bethesda, MD 20892, (301)-435– kotliars@mail.nih.gov. immunity. Evans Blue, a symmetric azo
1722, jollieda@csr.nih.gov. Name of Committee: Center for Scientific dye, has high binding affinity to
This notice is being published less than 15 Review Special Emphasis Panel; Drug albumin. Albumin binding ability of
days prior to the meeting due to the timing Discovery and Mechanisms of Antimicrobial Evans blue is utilized with CpGs and
limitations imposed by the review and Resistance.
tumor-specific antigens, in order to
funding cycle. Date: June 23, 2016.
Time: 1:00 p.m. to 2:00 p.m. leverage endogenous albumin that
Name of Committee: Brain Disorders and
Agenda: To review and evaluate grant increases the safety and the potency of
Clinical Neuroscience Integrated Review
Group; Clinical Neuroplasticity and applications. molecular vaccines. As such, the
Neurotransmitters Study Section. Place: American Inn of Bethesda, 8130 molecular entities provided here enable
Date: June 16–17, 2016. Wisconsin Avenue, Bethesda, MD 20814. efficient delivery and prolonged
Time: 8:00 a.m. to 5:00 p.m. Contact Person: John C Pugh, Ph.D., retention in lymph nodes and reduce
Agenda: To review and evaluate grant Scientific Review Officer, Center for systemic toxicity of Evans Blue and
applications. Scientific Review, National Institutes of enhanced the therapeutic potency of
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Place: Renaissance Mayflower Hotel, 1127 Health, 6701 Rockledge Drive, Room 1206,
molecular vaccines.
Connecticut Avenue NW., Washington, DC MSC 7808, Bethesda, MD 20892, (301) 435–
20036. 2398, pughjohn@csr.nih.gov. Potential Commercial Applications:
Contact Person: Suzan Nadi, Ph.D., (Catalogue of Federal Domestic Assistance • Cancer therapeutics
Scientific Review Officer, Center for Program Nos. 93.306, Comparative Medicine; • Infectious disease therapeutics
Scientific Review, National Institutes of 93.333, Clinical Research, 93.306, 93.333, • Lymph node specificity
Health, 6701 Rockledge Drive, Room 5217B, 93.337, 93.393–93.396, 93.837–93.844, • Higher stability/Lower toxicity
MSC 7846, Bethesda, MD 20892, 301–435– 93.846-93.878, 93.892, 93.893, National Development Stage:
1259, nadis@csr.nih.gov. Institutes of Health, HHS) • Early stage

VerDate Sep<11>2014 20:01 Jun 01, 2016 Jkt 238001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\02JNN1.SGM 02JNN1

Document Created: 2016-06-02 01:23:12
Document Modified: 2016-06-02 01:23:12

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 14, 2016.
FR Citation		81 FR 35372

81 FR 35372 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 106 (June 2, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health